Obliterative bronchiolitis after rituximab administration: A new manifestation of rituximab-associated pulmonary toxicity

Internal Medicine Journal

Volumn 42, Issue 5, 2012, Pages 597-599

  Shen, T ^a   Braude, S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

AGED; B CELL LYMPHOMA; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CASE REPORT; COUGHING; DYSPNEA; FATTY ACID DESATURATION; HUMAN; LETTER; LUNG FUNCTION TEST; LUNG TOXICITY; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; TREATMENT FAILURE;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BRONCHIOLITIS OBLITERANS; HUMANS; MALE;

EID: 84861444043     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2012.02778.x     Document Type: Letter

References (21)

1. Burton C, Kaczmarski R, Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003; 348: 2690-91. Discussion 2690-91.
2. Swords R, Power D, Fay M, O'Donnell R, Murphy PT. Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Am J Hematol 2004; 77: 103-4.
3. Jullien V, Perrin C, Peyrade F, Lemoigne F, Chichmanian R, Blaive B. Une pneumopathie alvéolo-interstitielle hypoxémiante associée à la prise de rituximab [Alveolar hypoxemic interstitial pneumonia related to rituximab therapy]. Rev Mal Respir 2004; 21: 407-10.
4. Leon RJ, Gonsalvo A, Salas R, Hidalgo NC. Rituximab-induced acute pulmonary fibrosis. Mayo Clin Proc 2004; 79: 949-53.
5. Herishanu Y, Polliack A, Leider-Trejo L, Grieff Y, Metser U, Naparstek E. Fatal interstitial pneumonitis related to rituximab-containing regimen. Clin Lymphoma Myeloma 2006; 6: 407-9.
6. Lee Y, Kyung SY, Choi SJ, Bang SM, Jeong SH, Shin DB etal. Two cases of interstitial pneumonitis caused by rituximab therapy. Korean J Intern Med 2006; 21: 183-6.
7. Mian M, Rass C, Hutarew G, Kofler B, Fiegl M, Greil R. Extensive organizing pneumonia during chemo-immunotherapy containing rituximab and G-CSF in a patient with diffuse large B-cell lymphoma: case report and review of the literature. Leuk Lymphoma 2006; 47: 1683-5.
8. Liu X, Hong X, Gu Y, Wang B, Luo Z, Cao J. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma. Leuk Lymphoma 2008; 49: 1778-83.
9. Wagner SA, Mehta AC, Laber DA. Rituximab-induced interstitial lung disease. Am J Hematol 2007; 82: 916-19.
10. Davis TA, White CA, Grillo-López AJ, Velásquez WS, Link B, Maloney DG etal. Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab. J Clin Oncol 1999; 17: 1851-7.
11. Byrd JC, Peterson BL, Morrison VA, Park K, Jacobson R, Hoke E etal. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood 2003; 101: 6-14.
12. Biehn SE, Kirk D, Rivera MP, Martinez AE, Khandani AH, Orlowski RZ. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma. Hematol Oncol 2006; 24: 234-7.
13. Bauer PR, Zent CS, Aubry M, Ryu JH. Recurrent fevers, cough, and pulmonary opacities in a middle-aged man. Chest 2010; 137: 1465-9.
14. Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 2005; 31: 456-73.
15. Alexandrescu DT, Dutcher JP, O'Boyle K, Albulak M, Oiseth S, Wiernik PH. Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma. Leuk Lymphoma 2004; 45: 2321-5.
16. Heresi GA, Farver CF, Stoller JK. Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab. Respiration 2008; 76: 449-53.
17. Montero AJ, McCarthy JJ, Chen G, Rice L. Acute respiratory distress syndrome after rituximab infusion. Int J Hematol 2005; 82: 324-6.
18. Saito B, Nakamaki T, Adachi D, Suzuki J, Tomoyasu S. Acute respiratory distress syndrome during the third infusion of rituximab in a patient with follicular lymphoma. Int J Hematol 2004; 80: 164-7.
19. Lioté H, Lioté F, Séroussi B, Mayaud C, Cadranel J. Rituximab-induced lung disease: a systematic literature review. Eur Respir J 2010; 35: 681-7.
20. Peerzada MM, Spiro TP, Daw HA. Pulmonary toxicities of biologics: a review. Anticancer Drugs 2010; 21: 131-9.
21. Epler GR. Constrictive bronchiolitis obliterans: the fibrotic airway disorder. Expert Rev Respir Med 2007; 1: 139-47.